4-Piperidineethanol CAS 622-26-4 Puritas >98.0% (GC) Factory

Description:

Nomen chemicum: 4-Piperidineethanol

CAS: 622-26-4

Puritas: >98.0% (GC)

Hyalina vel Alba ad Yellow Firmus vel Liquid

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4-Piperidineethanol (CAS: 622-26-4) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	4-Piperidineethanol
Synonyma	4-(2-Hydroxyethyl) piperidine;4-Ethanolpiperidine
CAS Number	622-26-4
CATTUS Number	RF-PI1921
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C7H15NO
M. Pondus	129.20
Solubilitas	Solube in Methanol fere diaphanum
Conditio vitare	Hygroscopic
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina vel Alba ad Yellow Firmus vel Liquid
Puritas / Analysis Methodus	>98.0% (GC)
Liquescens punctum	48.0~52.0℃
Humor (KF)	<0.50%
Totalis immunditias	<2.00%
Infrared Imaginis	Conformat ut Structure
Proton NMR Spectrum	Conformat ut Structure
Solubilitas in MeOH	Prope diaphanum
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

4-Piperidineethanol (CAS: 622-26-4), Reactant synthesim de: Acidum ursolicum derivatorum;Amodiaquina analoga pro curatione malariae cerebri;Spiroimidazolidinone NPC1L1 inhibitors;Piperazinyl pyridinum glutamatum ut ore tenus P2Y12 antagonistae pro inhibitione aggregationis platelet;Neurokinin-2 receptor antagonistarum;Hepatitis C virus NS5B polymerase inhibitores.4-Piperidineethanol in synthetica praeparatione ligamentorum cellularum allostericorum FAK inhibitores mediae adhibiti sunt.